Evidence map›Paper›PMID 21690174›Full record

ArticleCardiovascular research2011

Enhanced K(+)-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE(-/-) mice.

Timea Beleznai, Hiromichi Takano, Claire Hamill, Polina Yarova, Gillian Douglas, Keith Channon, Kim Dora

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. VEGF-A inhibits agonist-mediated CaThe Journal of physiology · 2018
    Article
  8. Article
  9. Review
  10. Review
  11. Conducted dilatation to ATP and KActa physiologica (Oxford, England) · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Characterization of the thoracodorsal artery: morphology and reactivity.Microcirculation (New York, N.Y. : 1994) · 2012
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Timea BeleznaiDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Hiromichi Takano
Claire Hamill
Polina Yarova
Gillian Douglas
Keith Channon
Kim Dora
University of Oxford · GBJohn Radcliffe Hospital · GB

Funding

British Heart Foundation FS/08/033/25111British Heart Foundation RG/07/003/23133Wellcome Trust 090532
6 · The paper itself

Abstract

aimsAgonists that evoke smooth muscle cell hyperpolarization have the potential to stimulate both local and conducted dilation. We investigated whether the endothelium-dependent vasodilators acetylcholine (ACh) and SLIGRL stimulated conducted dilation and whether this was altered by deficiency in apolipoprotein E (ApoE(-/-)). METHODS AND

resultsIsolated mesenteric arteries were cannulated, pressurized, and precontracted with phenylephrine. Agonists were either added to the bath to study local dilation or were restricted to one end of arteries to study conducted dilation. An enhanced sensitivity to both ACh and SLIGRL was observed in mesenteric arteries from ApoE(-/-) mice compared with wild-type controls. Inhibition of nitric oxide (NO) synthase blocked ACh responses, but had no effect on maximum dilation to SLIGRL. SLIGRL increased endothelial cell Ca(2+), hyperpolarized smooth muscle cells, and fully dilated arteries. The NO-independent dilation to SLIGRL was blocked with high [KCl] or Ca(2+)-activated K(+)-channel blockers. The hyperpolarization and dilation to SLIGRL passed through the artery to at least 2.5 mm upstream. The conducted dilation was not affected by a deficit in ApoE and could also be stimulated by ACh, suggesting NO itself could stimulate conducted dilation.

conclusionIn small mesenteric arteries of ApoE(-/-) mice, NO-independent dilation is enhanced. Since both NO-dependent and -independent pathways can stimulate local and conducted dilation, the potential for reducing vascular resistance is improved in these vessels.

Indexed as

VasodilationAcetylcholineAge FactorsAnimalsAortic DiseasesApolipoproteins EAtherosclerosisCalciumDisease Models, AnimalDose-Response Relationship, DrugEndothelium, VascularEnzyme InhibitorsMesenteric ArteriesMiceMice, Inbred C57BLMice, KnockoutAcetylcholineApolipoproteins ECalciumEnzyme InhibitorsNitric OxideNitric Oxide SynthaseOligopeptidesPotassium Channel BlockersPotassium Channelsseryl-leucyl-isoleucyl-glycyl-arginyl-leucineVasodilator Agents

Identifiers

PMID21690174
PMCPMC3193832
OpenAlexW1986147886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.